Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Titel:
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Auteur:
Sharma, Padmanee Callahan, Margaret K Bono, Petri Kim, Joseph Spiliopoulou, Pavlina Calvo, Emiliano Pillai, Rathi N Ott, Patrick A de Braud, Filippo Morse, Michael Le, Dung T Jaeger, Dirk Chan, Emily Harbison, Chris Lin, Chen-Sheng Tschaika, Marina Azrilevich, Alex Rosenberg, Jonathan E